Mutation Profiles May Aid in Treatment of Non –Clear-Cell Renal Cell Carcinoma

Analyzing somatic and germline mutations and MSI may reveal clinically actionable mutations in a proportion of patients with advanced RCC.

Source: CancerNetwork - May 8, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news